GWAS |
- Alzheimer disease and age of onset ( 26830138)
- Asthma ( 27611488)
- Coronary artery aneurysm in Kawasaki disease ( 26434682)
- Coronary artery calcification ( 23870195)
- Glucocorticoid-induced osteonecrosis ( 26265699)
- Glucocorticoid-induced osteonecrosis (age 10 years and older) ( 26265699)
- Glucocorticoid-induced osteonecrosis (time dependent analysis) ( 26265699)
- Obesity-related traits ( 23251661)
- Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis) ( 29678681)
- Plasma anti-thyroglobulin levels ( 29678681)
- Plasma anti-thyroid peroxidase levels ( 29678681)
- Response to fenofibrate (triglyceride levels) ( 27002377)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
|
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885)
- Bipolar disorder ( 31043756)
- Bipolar I disorder ( 31043756)
- Chronic kidney disease ( 26420894)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Copper levels ( 26025379)
- FEV1 ( 30804560)
- General risk tolerance (MTAG) ( 30643258)
- Hallux valgus ( 32131869)
- Hepatitis B ( 22004137)
- Laryngeal squamous cell carcinoma ( 25194280)
- Lung function (FVC) ( 30804560)
- Metabolite levels ( 23823483)
- Night sleep phenotypes ( 27126917)
- Refractive error ( 32231278)
- Rosacea symptom severity ( 29771307)
- Schizophrenia ( 28991256 25056061 29483656 30285260)
- Tenofovir clearance in HIV infection ( 26148204)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010)
- Waist circumference adjusted for BMI (smoking interaction) ( 28443625)
|